MedPath

Comparing the efficiency of the NEW device HFNC used as a method of oxygenation with traditional oxegenation devices like FACE MASK etc in preventing the respiratory failure after extubation of a patient.

Phase 3
Conditions
Health Condition 1: X- New Technology
Registration Number
CTRI/2024/08/071807
Lead Sponsor
AIIMS PATNA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age more than 18 years and less than 75 years

BMI less than 30 kg/m2

Minimum 12 hours and maximum 7days of intubation period

Exclusion Criteria

Tracheostomised patients

Pregnant patient

Patients with congestive heart disease

Re intubated patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the efficacy of High Flow Nasal Oxygenation in preventing reintubation within 48 hours of planned extubation by comparing the 1st, 6th, 12th, 24th, 48th hours ABG parameters and respiratory parameters with the NRM which may indcicate the need for re intubation.Timepoint: At 1st, 6th, 12th, 24th, 48th hours ABG parameters and respiratory parameters are recorded to look for any respiratory failure and rates of re intubation in
Secondary Outcome Measures
NameTimeMethod
The respiartory failure within 48 hours of extubation measures via ABG & Respiratory parametersTimepoint: 1st, 6th, 12th, 24th, 48th hours ABG parameters & respiratory parameters are measures to assess for respiratory failure.
© Copyright 2025. All Rights Reserved by MedPath